Company · CIK 0001772028
Scopus BioPharma Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001104659-23-093554 · 358.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-23-090580 · 195.5 KBSEC(opens sec.gov)
- 10-QQuarterly update0001410578-23-001787 · 4.3 MBSEC(opens sec.gov)
- 10-QQuarterly update0001410578-23-001110 · 3.9 MBSEC(opens sec.gov)
- 10-K/AScopus BioPharma Inc.0001104659-23-053138 · 433.6 KBSEC(opens sec.gov)
- 10-KAnnual report0001410578-23-000666 · 7.2 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-22-127517 · 199.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-22-124179 · 199.6 KBSEC(opens sec.gov)
- 10-QQuarterly update0001410578-22-003519 · 5.4 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-22-110330 · 266.7 KBSEC(opens sec.gov)
Insiders
- Battleman David S.Director
- Buckel David A.Director
- Gibson Robert JDirector, Vice Chairman
- Greenspan Ira ScottDirector, Executive Committee Chairman, 10% Owner
- Hofstein RaphaelDirector
- Hopper PaulDirector
- Horsager Alan MSee Remarks
- Lamstein Joshua RDirector, Chairman, 10% Owner
- Russell LesleyDirector
- Sanghrajka Ashish PDirector, President
Tickers
No tickers on record.
Addresses
business
420 LEXINGTON AVENUE, SUITE 300
NEW YORK, NY, 10170
mailing
420 LEXINGTON AVENUE, SUITE 300
NEW YORK, NY, 10170
Same industry